StemCells announces HuCNS-SC product positive Phase I/II interim data
The Phase I/II trial, which transplanted first cohort including three patients with a dose of 20 million cells at the thoracic site of injury having no neurological function,
The Phase I/II trial, which transplanted first cohort including three patients with a dose of 20 million cells at the thoracic site of injury having no neurological function,
The company was reportedly inspected by the FDA officials before giving approval some 10 days ago. Hindustan Antibiotics personnel manager T Das was quoted by Express India as
Canada’s Labour Minister Lisa Raitt said the Canadian Government is investing in the people, businesses and communities of southern Ontario to create jobs, growth and long-term prosperity. "Through
Janssen Infectious Diseases therapeutic area head Wim Parys said MDR-TB is a threat to public health and presents a new treatment challenge in controlling the disease. "This filing
As part of the agreement, Rancom A/S will distribute the full sample management solutions of BioSampling Systems range solutions for pharmaceutical and biotech companies, hospitals and clinical diagnostic
Smart FIX is an Intelligent Document Processing and Business Process Optimization solution to manage formatted, semi-formatted and unformatted documents in various sectors such as hospitality, retail, pharma, manufacturing and
The move will bring Galectin Therapeutics closer to its collaborator, Complex Carbohydrate Research Center at the University of Georgia. The Georgia corporate office, which will be placed in
Azzur Labs offers professional analytical compliant testing services for the pharmaceutical, biotechnology and cosmetic industries. Azzur Labs quality assurance manager Lisa Myles said based on the needs of
The $39.5m distribution center will lease a building and is expected to generate174 jobs. Virginia Governor Bob McDonnell was quoted by Virginia Business as saying that The Vitamin
EP-101, an inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist, delivered by an investigational eFlow nebulizer, demonstrated a statistically significant improvement in lung function compared to placebo